Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech | Ben Fidler | 12/30/16 | New York |
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors | Ben Fidler | 03/30/16 | New York |
Hear Lew Cantley, Others on Shaping NY Biotech on March 29 | Ben Fidler | 03/11/16 | New York |
New York City: En Route to a Bio Cluster | Louis Levy and Vicki Sato | 02/29/16 | New York |
Alexandria, Lodo Founders to Join NY’s Bio Disruptors on March 29 | Thea Bissell | 02/23/16 | New York |
Early Bird Special Ends Today for New York’s Life Science Disruptors | Thea Bissell | 02/02/16 | New York |
NYC’s Disruptive Biotech Startups take the Stage on March 29 | Ben Fidler | 01/21/16 | New York |
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More | Ben Fidler | 01/08/16 | Boston |
With $48M For Petra Pharma, Accelerator Places First NYC Bet | Ben Fidler | 01/06/16 | New York |
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech | Ben Fidler | 10/16/13 | Boston |
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut | Ben Fidler | 07/24/13 | Boston |
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More | Bernadette Tansey | 02/22/13 | New York |
Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars | Luke Timmerman | 02/20/13 | National |
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage | Arlene Weintraub | 10/11/11 | Boston |
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer | Ryan McBride | 08/19/10 | Boston |
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells | Luke Timmerman | 11/24/08 | Boston |